Authors' Reply to Robert P. Giugliano and Colleagues' Comment on: "Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance"

Drug Saf. 2021 Apr;44(4):505-506. doi: 10.1007/s40264-021-01054-2. Epub 2021 Feb 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Humans
  • Lung Diseases, Interstitial* / chemically induced
  • Pharmacovigilance*

Substances

  • Anticoagulants